Halothane
Specifications
151-67-7CAS Number
205-796-5EC Number
2-bromo-2-chloro-1,1,1-trifluoroethaneIUPAC Name
C2HBrClF3Chemical Formula
197.38 g/molMolecular Weight
halothane; 151-67-7; 2-BROMO-2-CHLORO-1,1,1-TRIFLUOROETHANE; Fluothane; Narcotane; Narcotan; Rhodialothan; Anestan; Ftorotan; Fluorotane; Ftuorotan; Halothan; Narkotan; Fluktan; Halotan; Halsan; Bromochlorotrifluoroethane; Phthorothanum; Halotano; Chalothane; Alotano; Freon 123B1; Halothanum; Fluorothane; Bromchlortrifluoraethanum; 1-Bromo-1-chloro-2,2,2-trifluoroethane; Ethane, 2-bromo-2-chloro-1,1,1-trifluoro-; Narcotann ne-spofa; 1,1,1-Trifluoro-2-bromo-2-chloroethane; 1,1,1-Trifluoro-2-chloro-2-bromoethane; 2,2,2-Trifluoro-1-chloro-1-bromoethane; DTXSID4025371; NSC 143490; UQT9G45D1P; Ethane, 1-bromo-1-chloro-2,2,2-trifluoro-; NSC-143490; CHEBI:5615; DTXCID605371; NSC143490; Rhidialothan; (+-)-Halothane; RefChem:5877; 2,2,2-trifluoro-1-bromo-1-chloroethane; Fluothane, Halothane, USP; N01AB01; 1,1,1-trifluoro-2,2-chlorobromoethane; (2RS)-2-Bromo-2-chloro-1,1,1-trifluoroethane; 205-796-5; Halan; Ftorotan [Russian]; Alotano [DCIT]; Halotano [INN-Spanish]; Halothanum [INN-Latin]; Narcotann NE-spofa [Russian]; CF3CHClBr; MFCD00009602; CHEMBL931; NCGC00090868-01; Ethane, bromochlorotrifluoro-; Fluothane (TN); CAS-151-67-7; 2-Brom-2-chlor-1,1,1-trifluorethan; CCRIS 6244; HSDB 6753; Halothane [Anaesthetics, volatile]; EINECS 205-796-5; UNII-UQT9G45D1P; BRN 1736947; Halothane [USP:INN:BAN:JAN]; (+-)-2-Bromo-2-chloro-1,1,1-trifluoroethane; WLN: GYEXFFF; HALOTHANE [INN]; HALOTHANE [JAN]; HALOTHANE [MI]; Ethane,1,1-trifluoro-; Halon 2311; HALOTHANE [HSDB]; HALOTHANE [VANDF]; Epitope ID:150925; HALOTHANE [MART.]; (.+/-.))-Halothane; HALOTHANE [WHO-DD]; HALOTHANE [WHO-IP]; SCHEMBL25588; SCHEMBL337605; Halothane (JP18/USP/INN); HALOTHANE [GREEN BOOK]; GTPL2401; orb1226161; orb1310134; HALOTHANE [EP IMPURITY]; HALOTHANE [ORANGE BOOK]; Ethane, 2-bromo-2-chloro-1,1,1-trifluoro-, (+-)-; HALOTHANE [EP MONOGRAPH]; (RS)-2-Bromo-2-chloro-1,; BCQZXOMGPXTTIC-UHFFFAOYSA-; HALOTHANE [USP MONOGRAPH]; HALOTHANUM [WHO-IP LATIN]; HMS2094K17; HMS3885H08; HMS5083P13; Pharmakon1600-01505434; HY-B1010; Tox21_111033; Tox21_200850; BDBM50112212; EBC-03062; MSK157120; NSC760138; s4570; AKOS006227959; Tox21_111033_1; 1,1-Trifluoro-2-bromo-2-chloroethane; 1,1-Trifluoro-2-chloro-2-bromoethane; 2,2-Trifluoro-1-chloro-1-bromoethane; 2-Bromo-2-chloro-1,1-trifluoroethane; 2-Bromo-2-chloro-111-trifluoroethane; CCG-213438; CS-4523; DB01159; NSC-760138; 1-bromo-1-chloro-2,2,2-trifluorethane; NCGC00090868-02; NCGC00090868-03; NCGC00090868-05; NCGC00090868-06; NCGC00258404-01; FB165735; TS-07651; SBI-0206928.P001; DB-043111; NS00009038; EN300-90288; C07515; D00542; H11280; Q32921; AB01563314_01; SR-05000001969; 2-Bromo-2-chloro-1,1,1-trifluoroethane, >=99%; InChI=1/C2HBrClF3/c3-1(4)2(5,6)7/h1H; SR-05000001969-1; BRD-A20550616-001-02-9; (+/-)-2-BROMO-2-CHLORO-1,1,1-TRIFLUOROETHANE; 2-Bromo-2-chloro-1,1,1-trifluoroethane (FC-123B1); Z1201617125; 2-Bromo-2-chloro-1 pound not1 pound not1-trifluoroethane; 2-Bromo-2-chloro-1,1,1-trifluoroethane, >=99.0% (GC); ETHANE, 2-BROMO-2-CHLORO-1,1,1-TRIFLUORO-,(+/-)-; Halothane, United States Pharmacopeia (USP) Reference StandardSynonyms
